News

Latest News

Next Week: Rubio Staff Hosts Mobile Office Hours

U.S. Senator Marco Rubio’s (R-FL) office will host in-person and virtual Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of...

read more

Rubio Habla en Maxima 92.5 de Tampa Bay

El senador estadounidense Marco Rubio (R-FL) habló con Nio Encendio de Maxima 92.5 de Tampa Bay, sobre cómo la inflación ha impactado a las familias, sobre las olas de migración ilegal, sobre el juicio político de Biden vs. el de Trump, sobre el canje de prisioneros...

read more

ICYMI: Rubio Joins All Things Considered

U.S. Senator Marco Rubio (R-FL) joined National Public Radio’s All Things Considered to discuss his plan to expand the child tax credit for working families. See below for the full transcript and listen to the edited interview here. On the connection between the child...

read more

Rubio: “Very Strong” Forthcoming Action by Trump Administration on Supply Chain

Mar 11, 2020 | Press Releases

Washington, D.C. — U.S. Senator Marco Rubio (R-FL) praised the Trump Administration’s forthcoming Executive Order that will enforce Buy American Act requirements for pharmaceuticals and medical supplies. Restoring Buy American Act preferences for pharmaceuticals is a part of Rubio’s coronavirus plan released last month. On Thursday, March 12, 2020, Rubio, Chairman of the Senate Committee on Small Business and Entrepreneurship, will convene a hearing titled, “The Coronavirus and America’s Small Business Supply Chain.”
 
“The coronavirus outbreak has been a wake-up call that we must combat America’s supply chain vulnerabilities and dependence on China in critical sectors of our economy,” Rubio said. “The Trump Administration’s forthcoming Executive Order is a very strong first step toward increasing domestic production by enforcing Buy American requirements for pharmaceuticals and medical supplies, as well as fast-tracking FDA approval of critical products impacted by the coronavirus outbreak’s strain on the supply chain.”
 
Last year, Rubio wrote in Modern Healthcare that “[w]hen it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.” Rubio released a report last February detailing critical vulnerabilities in America’s medical supply chain, warning, “the U.S. runs the risk of losing important components of its medical supply chain to China’s government-backed industry.”
 
A timeline of Rubio’s actions related to coronavirus can be found here.